Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560322015> ?p ?o ?g. }
- W2560322015 endingPage "122" @default.
- W2560322015 startingPage "114" @default.
- W2560322015 abstract "OBJECTIVE Patients with arteriovenous malformations (AVMs) treated with Gamma Knife radiosurgery (GKRS) subsequent to embolization suffer from elevated local failure rates and differences in adverse radiation effects. Onyx is a common embolic material for AVMs. Onyx is formulated with tantalum, a high atomic number (Z = 73) element that has been investigated as a source of dosimetric uncertainty contributing to the less favorable clinical results. However, prior studies have not modeled the complicated anatomical and beam geometries characteristic of GKRS. This study investigated the magnitude of dose perturbation that can occur due to Onyx embolization using clinically realistic anatomical and Gamma Knife beam models. METHODS Leksell GammaPlan (LGP) was used to segment the AVM nidus and areas of Onyx from postcontrast stereotactic MRI for 7 patients treated with GKRS postembolization. The resulting contours, skull surface, and clinically selected dose distributions were exported from LGP in DICOM-RT (Digital Imaging and Communications in Medicine–radiotherapy) format. Isocenter locations and dwell times were recorded from the LGP database. Contours were converted into 3D mesh representations using commercial and in-house mesh-editing software. The resulting data were imported into a Monte Carlo (MC) dose calculation engine (Pegasos, Elekta Instruments AB) with a beam geometry for the Gamma Knife Perfexion. The MC-predicted dose distributions were calculated with Onyx assigned manufacturer-reported physical constants (MC-Onyx), and then compared with corresponding distributions in which Onyx was reassigned constants for water (MC-water). Differences in dose metrics were determined, including minimum, maximum, and mean dose to the AVM nidus; selectivity index; and target coverage. Combined differences in dose magnitude and distance to agreement were calculated as 3D Gamma analysis passing rates using tolerance criteria of 0.5%/0.5 mm, 1.0%/1.0 mm, and 3.0%/3.0 mm. RESULTS Overall, the mean percentage differences in dose metrics for MC-Onyx relative to MC-water were as follows; all data are reported as mean (SD): minimum dose to AVM = −0.7% (1.4%), mean dose to AVM = 0.1% (0.2%), maximum dose to AVM = 2.9% (5.0%), selectivity = 0.1% (0.2%), and coverage = −0.0% (0.2%). The mean percentage of voxels passing at each Gamma tolerance were as follows: 99.7% (0.1%) for 3.0%/3.0 mm, 98.2% (0.7%) for 1.0%/1.0 mm, and 52.1% (4.4%) for 0.5%/0.5 mm. CONCLUSIONS Onyx embolization appears to have a detectable effect on the delivered dose distribution. However, the small changes in dose metrics and high Gamma passing rates at 1.0%/1.0 mm tolerance suggest that these changes are unlikely to be clinically significant. Additional sources of delivery and biological uncertainty should be investigated to determine the root cause of the observed less favorable postembolization GKRS outcomes." @default.
- W2560322015 created "2016-12-16" @default.
- W2560322015 creator A5006425275 @default.
- W2560322015 creator A5043879863 @default.
- W2560322015 creator A5046921613 @default.
- W2560322015 creator A5059704827 @default.
- W2560322015 creator A5068443720 @default.
- W2560322015 date "2016-12-01" @default.
- W2560322015 modified "2023-10-06" @default.
- W2560322015 title "Dosimetric effects of Onyx embolization on Gamma Knife arteriovenous malformation dose distributions" @default.
- W2560322015 cites W1522231572 @default.
- W2560322015 cites W1538766874 @default.
- W2560322015 cites W1798053236 @default.
- W2560322015 cites W1966074517 @default.
- W2560322015 cites W1967121735 @default.
- W2560322015 cites W1990827058 @default.
- W2560322015 cites W1995525739 @default.
- W2560322015 cites W2001662450 @default.
- W2560322015 cites W2002199411 @default.
- W2560322015 cites W2017142224 @default.
- W2560322015 cites W2026616100 @default.
- W2560322015 cites W2031895991 @default.
- W2560322015 cites W2032474964 @default.
- W2560322015 cites W2035602673 @default.
- W2560322015 cites W2044652292 @default.
- W2560322015 cites W2049473654 @default.
- W2560322015 cites W2054474589 @default.
- W2560322015 cites W2055825000 @default.
- W2560322015 cites W2060705975 @default.
- W2560322015 cites W2065540596 @default.
- W2560322015 cites W2078743005 @default.
- W2560322015 cites W2079576893 @default.
- W2560322015 cites W2085947941 @default.
- W2560322015 cites W2086613698 @default.
- W2560322015 cites W2086673307 @default.
- W2560322015 cites W2090314434 @default.
- W2560322015 cites W2094112956 @default.
- W2560322015 cites W2100788029 @default.
- W2560322015 cites W2102766489 @default.
- W2560322015 cites W2103728369 @default.
- W2560322015 cites W2105051668 @default.
- W2560322015 cites W2105380930 @default.
- W2560322015 cites W2107253139 @default.
- W2560322015 cites W2112164139 @default.
- W2560322015 cites W2123346148 @default.
- W2560322015 cites W2124275134 @default.
- W2560322015 cites W2146578980 @default.
- W2560322015 cites W2149710876 @default.
- W2560322015 cites W2155715916 @default.
- W2560322015 cites W2183101157 @default.
- W2560322015 cites W3152313833 @default.
- W2560322015 cites W4239930261 @default.
- W2560322015 cites W4321429365 @default.
- W2560322015 doi "https://doi.org/10.3171/2016.6.gks161502" @default.
- W2560322015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27903195" @default.
- W2560322015 hasPublicationYear "2016" @default.
- W2560322015 type Work @default.
- W2560322015 sameAs 2560322015 @default.
- W2560322015 citedByCount "10" @default.
- W2560322015 countsByYear W25603220152017 @default.
- W2560322015 countsByYear W25603220152018 @default.
- W2560322015 countsByYear W25603220152019 @default.
- W2560322015 countsByYear W25603220152020 @default.
- W2560322015 countsByYear W25603220152021 @default.
- W2560322015 countsByYear W25603220152022 @default.
- W2560322015 crossrefType "journal-article" @default.
- W2560322015 hasAuthorship W2560322015A5006425275 @default.
- W2560322015 hasAuthorship W2560322015A5043879863 @default.
- W2560322015 hasAuthorship W2560322015A5046921613 @default.
- W2560322015 hasAuthorship W2560322015A5059704827 @default.
- W2560322015 hasAuthorship W2560322015A5068443720 @default.
- W2560322015 hasBestOaLocation W25603220151 @default.
- W2560322015 hasConcept C126838900 @default.
- W2560322015 hasConcept C181401712 @default.
- W2560322015 hasConcept C2776035437 @default.
- W2560322015 hasConcept C2778749279 @default.
- W2560322015 hasConcept C2779603958 @default.
- W2560322015 hasConcept C2780387249 @default.
- W2560322015 hasConcept C2780643987 @default.
- W2560322015 hasConcept C2910939485 @default.
- W2560322015 hasConcept C2989005 @default.
- W2560322015 hasConcept C509974204 @default.
- W2560322015 hasConcept C71924100 @default.
- W2560322015 hasConceptScore W2560322015C126838900 @default.
- W2560322015 hasConceptScore W2560322015C181401712 @default.
- W2560322015 hasConceptScore W2560322015C2776035437 @default.
- W2560322015 hasConceptScore W2560322015C2778749279 @default.
- W2560322015 hasConceptScore W2560322015C2779603958 @default.
- W2560322015 hasConceptScore W2560322015C2780387249 @default.
- W2560322015 hasConceptScore W2560322015C2780643987 @default.
- W2560322015 hasConceptScore W2560322015C2910939485 @default.
- W2560322015 hasConceptScore W2560322015C2989005 @default.
- W2560322015 hasConceptScore W2560322015C509974204 @default.
- W2560322015 hasConceptScore W2560322015C71924100 @default.
- W2560322015 hasIssue "Supplement_1" @default.
- W2560322015 hasLocation W25603220151 @default.
- W2560322015 hasLocation W25603220152 @default.
- W2560322015 hasOpenAccess W2560322015 @default.